GENE ONLINE|News &
Opinion
Blog

2018-05-12|

May 12, 1910: British Biochemist Dorothy Hodgkin Was Born

by GeneOnline
Share To

Dorothy Mary Crowfoot Hodgkin (May 12, 1910 – July 29, 1994) was a British biochemist. Hodgkin began the research in X-ray crystallography during her studies at Somerville College, Oxford. She promoted the use of advanced X-ray crystallography to determine the three-dimensional structure of biological macromolecules. Some of the most influential findings was confirming the structure of penicillin and deciphering structure of vitamin B12. For this she was awarded the 1964 Nobel Prize in Chemistry. In 1969, after 35 years of work and 5 years after receiving the Nobel Prize, she finally deciphered the structure of insulin. X-ray crystallography became a widely used tool in molecular biology, and played a crucial role in determining important structure of many biomolecules later. Dorothy is considered one of the pioneer scientists in the field of X-ray crystallography of biomolecules.

Reference
https://www.nobelprize.org/nobel_prizes/chemistry/laureates/1964/hodgkin-bio.html

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
R&D
An Updated View on the “Central Dogma” of Molecular Biology
2023-01-03
Svante Pääbo Wins Physiology or Medicine Nobel Prize for Human Evolution Discoveries
2022-10-06
Three Scientists Jointly Win Nobel Prize for Innovations in Click Chemistry
2022-10-06
LATEST
BIO 2023 Coming to Boston, with Over 60 Taiwanese Organizations to Share their Achievements
2023-06-02
2023 ASGCT Annual Meeting: Showcase of Exciting New Research, with a Focus on Clinical Applications
2023-06-02
Pfizer’s RSV Vaccine Gets FDA Approval for Use in Older Adults
2023-05-31
Brazil’s Evolving ESG Landscape from the Amazon to Atlantic Forest
2023-05-31
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD, PhD
2023-05-26
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
Scroll to Top